Saturday 17 October 2026
Export ASPI’s income statement to Excel — free account
ASP Isotopes Inc.
ASPI Basic Materials Chemicals
ASP Isotopes Inc.’s revenue for fiscal 2025 (year ended December 2025) was $23.8 million, up 475.5% from fiscal 2024. In the quarter to June 2026, revenue grew 327.6%, EPS grew 73.8%, free cash flow fell 182.9% and total debt rose 162.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.14
0.07
−3.17%
Follow ASPI
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | 1.25 | 0.28 | 1.65 | 3.65 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | 3.75 | 2.20 | 9.33 | 14.49 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | 4 | 4 | 76 | 136 | 271 | ||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | 0.00 | 0.01 | 0.03 | 0.09 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 0 | 4 | 24 | ||||
| Gross margin, % | — | — | — | — | — | 0.00 | 0.00 | 32.10 | 38.59 | 14.28 | |||||
| EBT | — | — | — | — | — | 0 | (5) | (16) | (32) | (160) | |||||
| EBT margin, % | — | — | — | — | — | 0.00 | 0.00 | (3,764.50) | (779.73) | (669.05) | |||||
| Net income | — | — | — | — | — | 0 | (5) | (16) | (32) | (160) | |||||
| Depreciation | — | — | — | — | — | 0 | 0 | 0 | 0 | 2 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 0.00 | 0.01 | 0.07 | 0.29 | ||||
| Earnings | — | — | — | — | — | (0.08) | (0.18) | (0.49) | (0.63) | (2.11) | |||||
| Cash flow | — | — | — | — | — | 0.00 | (0.11) | (0.16) | (0.30) | (0.46) | |||||
| Capex | — | — | — | — | — | 0.00 | (0.17) | (0.07) | (0.20) | (0.12) | |||||
| Free cash flow | — | — | — | — | — | 0.00 | (0.28) | (0.23) | (0.50) | (0.57) | |||||
| Book value | — | — | — | — | — | 0.17 | 0.37 | 0.57 | 0.92 | 3.17 | |||||
| Shares, m | — | — | — | — | — | 34 | 27 | 33 | 56 | 83 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | 0.00 | 60.86 | 18.62 | |||||
| P/B | — | — | — | — | — | — | — | 3.06 | 4.93 | 1.69 | |||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 54.70 | 13.36 | |||||
| EV/FCF | — | — | — | — | — | — | — | (6.50) | (8.08) | (6.72) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | 0 | (3) | (5) | (17) | (38) | ||||
| Capex | — | — | — | — | — | 0 | (4) | (2) | (11) | (10) | |||||
| Free cash flow | — | — | — | — | — | 0 | (7) | (8) | (28) | (47) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 3 | 1 | 5 | 59 | 367 | ||||
| Total debt | — | — | — | — | — | 1 | 1 | 1 | 36 | 218 | |||||
| Net debt | — | — | — | — | — | (2) | (2) | (7) | (26) | (115) | |||||
| Shareholders’ equity | — | — | — | — | — | 6 | 10 | 19 | 51 | 263 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | (50.36) | (81.35) | (57.62) | (59.12) | ||||
| ROIC | — | — | — | — | — | 0.00 | (38.84) | (86.43) | (64.22) | (25.32) | |||||
| ROE | — | — | — | — | — | 0.00 | (62.54) | (113.70) | (100.33) | (111.50) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
ASP Isotopes Inc. vs peers in Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| LXU Lsb Industries Inc. | $753.1M | 21.3× | 12.8× | +11.10% (above 0%: growing) | n/m | +9,653.02% (above 0%: growing) | 6.82% | (1.63%) | Compare |
| WLKP Westlake Chemical Partners LP | $734.5M | 12.8× | 12.3× | −0.01% (below 0%: shrinking) | −2.44% (below 0%: shrinking) | +866.65% (above 0%: growing) | 31.91% | 29.39% | Compare |
| TROX Tronox Holdings PLC | $565.3M | — (loss-making) | — (loss-making) | +18.74% (above 0%: growing) | n/m | +241.51% (above 0%: growing) | 6.34% | (2.42%) | Compare |
| RYAM Rayonier Advanced Materials Inc. | $481.0M | — (loss-making) | — (loss-making) | +10.61% (above 0%: growing) | n/m | +69.92% (above 0%: growing) | 6.10% | (1.69%) | Compare |
| ASIX AdvanSix | $445.5M | — (loss-making) | 24.1× | +2.75% (above 0%: growing) | −89.74% (below 0%: shrinking) | −49.21% (below 0%: shrinking) | 7.38% | 2.15% | Compare |
| VHI Valhi, Inc. | $415.2M | — (loss-making) | 7.0× | +9.82% (above 0%: growing) | +2,500.00% (above 0%: growing) | +435.16% (above 0%: growing) | 22.56% | 9.88% | Compare |
| ASPI ASP Isotopes Inc. | $338.8M | — (loss-making) | — (loss-making) | +327.63% (above 0%: growing) | n/m | −182.92% (below 0%: shrinking) | 28.89% | (667.48%) | |
| BAK Braskem S.A. | $312.3M | — (loss-making) | — | −99.99% (below 0%: shrinking) | n/m | +611.13% (above 0%: growing) | 80.35% | 48.61% | Compare |
| ACNT Ascent Industries Co. | $122.1M | — (loss-making) | — (loss-making) | +37.61% (above 0%: growing) | −89.23% (below 0%: shrinking) | −97.54% (below 0%: shrinking) | 21.62% | (1.02%) | Compare |
| Median of peers | $463.2M | — | 12.6× | +10.21% | −45.83% | +338.34% | 14.50% | 0.56% |
ASP Isotopes Inc. (ASPI) key facts
- Strength: ASP Isotopes Inc.’s revenue for fiscal 2025 (year ended December 2025) was $23.8 million, up 475.5% from fiscal 2024.
- ASP Isotopes Inc. (ASPI) is a Chemicals company in the Basic Materials sector, listed on Nasdaq.
- As of October 16, 2026, ASPI traded at $2.14, a market capitalization of $338.8 million.
- Return on equity was −111.5% and debt-to-equity 0.96.
- Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 1.02 (distress zone) for fiscal 2025.